| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 82.476 | 301.885 | 365.237 | 341.792 |
| Total Income - EUR | - | - | - | - | - | - | 82.682 | 302.911 | 367.994 | 344.011 |
| Total Expenses - EUR | - | - | - | - | - | - | 71.595 | 180.742 | 280.503 | 259.546 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 11.086 | 122.170 | 87.491 | 84.465 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 10.472 | 119.451 | 84.275 | 74.417 |
| Employees | - | - | - | - | - | - | 2 | 5 | 6 | 6 |
Check the financial reports for the company - Niacin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 21.847 | 17.166 | 15.664 | 8.083 |
| Current Assets | - | - | - | - | - | - | 34.463 | 181.273 | 140.607 | 128.789 |
| Inventories | - | - | - | - | - | - | 18.452 | 21.264 | 21.735 | 20.869 |
| Receivables | - | - | - | - | - | - | 4.382 | 88.098 | 4.306 | 68.072 |
| Cash | - | - | - | - | - | - | 11.629 | 71.911 | 114.566 | 39.848 |
| Shareholders Funds | - | - | - | - | - | - | 10.512 | 119.500 | 120.234 | 74.467 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 45.840 | 78.957 | 36.275 | 62.424 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Niacin S.r.l.